HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease.

Häger M, Zivkovic M, Gandhi PS, Rasmussen C, Bonvoisin C, Harrison RA, Poulsen E, Huskens D, Roest M, Ferrara F, Naretto A, Renaud L, Olsen OH, Eskesen NO, Holten-Andersen L, Malladi R, Rea CJ, Sørensen B, Urbanus RT, Østergaard H.

Open source

DOI: 10.1182/bloodadvances.2025018516
Published: 2026-04-01
Container: Blood Adv
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025018516,
  title = {HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease.},
  author = {Häger M and  Zivkovic M and  Gandhi PS and  Rasmussen C and  Bonvoisin C and  Harrison RA and  Poulsen E and  Huskens D and  Roest M and  Ferrara F and  Naretto A and  Renaud L and  Olsen OH and  Eskesen NO and  Holten-Andersen L and  Malladi R and  Rea CJ and  Sørensen B and  Urbanus RT and  Østergaard H.},
  year = {2026},
  journal = {Blood Adv},
  doi = {10.1182/bloodadvances.2025018516},
  url = {https://doi.org/10.1182/bloodadvances.2025018516}
}

RIS

TY  - JOUR
TI  - HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease.
AU  - Häger M
AU  -  Zivkovic M
AU  -  Gandhi PS
AU  -  Rasmussen C
AU  -  Bonvoisin C
AU  -  Harrison RA
AU  -  Poulsen E
AU  -  Huskens D
AU  -  Roest M
AU  -  Ferrara F
AU  -  Naretto A
AU  -  Renaud L
AU  -  Olsen OH
AU  -  Eskesen NO
AU  -  Holten-Andersen L
AU  -  Malladi R
AU  -  Rea CJ
AU  -  Sørensen B
AU  -  Urbanus RT
AU  -  Østergaard H.
PY  - 2026
JO  - Blood Adv
DO  - 10.1182/bloodadvances.2025018516
UR  - https://doi.org/10.1182/bloodadvances.2025018516
ER  -

APA

M, H., M, Z., PS, G., C, R., C, B., RA, H., E, P., D, H., M, R., F, F., A, N., L, R., OH, O., NO, E., L, H., R, M., CJ, R., B, S., RT, U., & H., Ø. (2026). HMB-002: a monovalent antibody that elevates circulating VWF and FVIII levels for treatment of von Willebrand disease.. Blood Adv. https://doi.org/10.1182/bloodadvances.2025018516

Source records

europe-pmc · retrieved 2026-09-26T10:13:08.114Z